EPB41L4A-DT: A Drug Target / Disease Biomarker (G54508)

Target Name: EPB41L4A-DT

NCBI ID: G54508

Other Name(s): EPB41L4A-AS2 | EPB41L4A divergent transcript

EPB41L4A-DT: A Drug Target / Disease Biomarker

EPB41L4A-DT is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the E-cadherin family, which is a group of transmembrane proteins that play a role in cell-cell adhesion.

One of the main functions of EPB41L4A-DT is to contribute to the formation of tight junctions, which are specialized structures that mediate the transfer of electrical signals between cells. tight junctions are essential for maintaining the integrity of the blood-brain barrier, which is responsible for maintaining the barrier between the brain and the rest of the body, and for ensuring the delivery of essential nutrients and oxygen to the brain.

EPB41L4A-DT is also involved in the regulation of cell growth and differentiation. It has been shown to play a role in the development and maintenance of neural stem cells, which are a source of cells that can give rise to a wide range of tissues and organs in the body.

In addition to its role in cell-cell adhesion and cell growth, EPB41L4A-DT has also been shown to be involved in the regulation of cell-cell interactions and the development of tissues. For example, it has been shown to play a role in the development of heart tissue and in the regulation of ion channels in the heart.

Due to its involvement in these various functions, EPB41L4A-DT has been identified as a potential drug target. Studies have shown thatEPB41L4A-DT can be targeted with small molecules, such as those that inhibit its activity as a protein or that interfere with its interactions with other proteins.

In addition to its potential use as a drug target, EPB41L4A-DT has also been studied as a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that EPB41L4A-DT is overexpressed in various types of cancer, which suggests that it may be a useful biomarker for the diagnosis and treatment of these diseases.

Overall, EPB41L4A-DT is a protein that is involved in a wide range of physiological functions in the body. Its potential as a drug target and biomarker make it an attractive target for research in the fields of neuroscience and medicine. Further studies are needed to fully understand its role and potential as a drug and biomarker.

Protein Name: EPB41L4A Divergent Transcript

More Common Targets